Showing results (1-10 of 1,524) with videos related to
Sort By:
Pageof 153
JCO Clinical Cancer Informatics|October 31, 2023
Statistical Interpretation and Comparison of Waterfall PlotsMo Huang, Cong Chen, Linda Z SunJournal of Biopharmaceutical Statistics|April 23, 2009
Optimal two-stage randomized multinomial designs for Phase II oncology trialsLinda Z Sun, Cong Chen, Kamlesh PatelContemporary Clinical Trials|June 16, 2019
Testing monotherapy and combination therapy in one trial with biomarker considerationLinda Z Sun, S Peter Kang, Cong ChenPharmaceutical Statistics|September 26, 2025
Adjustment for Inconsistency in Adaptive Phase 2/3 Designs With Dose OptimizationCong Chen, Mo Huang, Xuekui ZhangContemporary Clinical Trials|August 19, 2025
Adaptive phase 2/3 design with dose optimizationCong Chen, Mo Huang, Xuekui ZhangContemporary Clinical Trials|May 18, 2021
Independent action models and prediction of combination treatment effects for response rate, duration of response and tumor size change in oncology drug developmentLinda Z Sun, Cai Wu, Xiaoyun Li, et al.Biometrical Journal. Biometrische Zeitschrift|December 17, 2024
Adjusted Inference for Multiple Testing Procedure in Group-Sequential DesignsYujie Zhao, Qi Liu, Linda Z Sun, et al.Biometrical Journal. Biometrische Zeitschrift|June 15, 2022
A unified framework for weighted parametric group sequential designKeaven M Anderson, Zifang Guo, Jing Zhao, et al.Biometrical Journal. Biometrische Zeitschrift|January 5, 2006
A note on penalty-free interim analyses of clinical studies with binary responsesCong ChenContemporary Clinical Trials|March 15, 2023
To go or not to go in phase 2/3 oncology trials, a critical question with a unified answerCong ChenPageof 153